Related Experiment Video
Updated: May 14, 2026
06:27
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
[Peritoneal dialysis and renal transplantation]
1Service de néphrologie, Département des spécialités de médecine, HUG, 1211 Genève 14.
Revue Medicale Suisse
|February 16, 2013
Summary
Individualized bicarbonate solutions help manage metabolic acidosis. Advances in peritoneal dialysis and epoietin-beta therapy show promise for improved patient outcomes in kidney disease and transplantation.
Area of Science:
- Nephrology
- Renal Replacement Therapy
- Transplantation Medicine
Context:
- Metabolic acidosis management requires tailored bicarbonate solutions.
- Peritoneal dialysis (PD) efficiency can be optimized.
- Epoietin-beta therapy impacts renal transplant recipients.
- Calcineurin inhibitors and sirolimus influence outcomes post-transplant.
- Atypical hemolytic uremic syndrome (aHUS) treatment is evolving.
Purpose:
- To review recent advancements in nephrology, focusing on metabolic acidosis, peritoneal dialysis, renal transplantation, and aHUS.
- To highlight strategies for improving dialysis efficiency and patient survival.
- To discuss therapeutic options and their impact on specific patient populations.
Summary:
- Individualized bicarbonate prescriptions offer control over metabolic acidosis.
- Optimizing dwell time and fill volume in intermittent automated peritoneal dialysis (APD) enhances dialysis efficiency.
- Continuous flow PD presents a significant improvement in dialysis efficiency.
- Normalized hemoglobin levels with epoietin-beta correlate with better graft survival in renal transplant recipients.
- Switching from calcineurin inhibitors to sirolimus after squamous-cell carcinoma improves disease-free survival.
- Eculizumab is effective in preventing and treating atypical hemolytic uremic syndrome.
Impact:
- These findings support personalized treatment strategies in nephrology.
- Optimized PD protocols can lead to better patient outcomes.
- Therapeutic advancements improve graft survival and cancer-free survival in transplant patients.
- Novel treatments offer new hope for managing rare but serious conditions like aHUS.
Related Concept Videos
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:30Peritoneal Dialysis I: Introduction and Procedure
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...